Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt structure
|
Common Name | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate salt | ||
|---|---|---|---|---|
| CAS Number | 202463-00-1 | Molecular Weight | 3273.83 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C150H246N44O38 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) trifluoroacetate saltAcetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist[1]. |
| Name | N-Acetyl-L-histidyl-D-phenylalanyl-L-alpha-aspartyl-L-alanyl-L-valyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucyl-L-lysyl-L-arginyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-isoleucyl-L-leucinamide |
|---|
| Description | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27), a vasoactive intestinal peptide (VIP), is a VIP1 antagonist[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C150H246N44O38 |
|---|---|
| Molecular Weight | 3273.83 |